1. Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves’ Ophthalmopathy
   Xingtong Liu et al, 2021, Endocrine Practice CrossRef
2. The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves’ ophthalmopathy compared to clinical activity scores
   Mengda Jiang et al, 2022, Endocrine CrossRef
3. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study
   Yang Gao et al, 2022, BMC Ophthalmology CrossRef
4. Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy
   Dide Wu et al, 2021, European Journal of Radiology CrossRef
5. Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI
   Lu Chen et al, 2020, International Journal of Endocrinology CrossRef
6. Current insights of applying MRI in Graves’ ophthalmopathy
   Cheng Song et al, 2022, Frontiers in Endocrinology CrossRef
7. Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment
   Faraat Ali et al, 2021, International Ophthalmology CrossRef
8. Investigation of lacrimal gland and extraocular muscle in thyroid eye disease patients with severe subjective dry eye disease: a multiparametric magnetic resonance imaging study
   Xulin Liao et al, 2024, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef
9. Usefulness of readout-segmented EPI-based diffusion tensor imaging of lacrimal gland for detection and disease staging in thyroid-associated ophthalmopathy
   Lu Chen et al, 2021, BMC Ophthalmology CrossRef
10. Delineation of the lacrimal vein: a magnetic resonance imaging study
    Satoshi Tsutsumi et al, 2023, Surgical and Radiologic Anatomy CrossRef
11. Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review
    Mizuki Tagami et al, 2022, Clinical Ophthalmology CrossRef
12. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management
    Alexander D. Blandford et al, 2017, Expert Review of Ophthalmology CrossRef
13. Computed tomography and magnetic resonance imaging approaches to Graves’ ophthalmopathy: a narrative review
    Rafael Luccas et al, 2024, Frontiers in Endocrinology CrossRef
14. Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy
    Mengsha Zou et al, 2022, European Radiology CrossRef
15. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease
    Pav Gounder et al, 2023, Thyroid Research CrossRef
16. Radiological measurements of lacrimal gland in thyroid eye disease
    Carmelo Caltabiano et al, 2024, International Ophthalmology CrossRef
17. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance
    Lu Chen et al, 2021, The British Journal of Radiology CrossRef
18. Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
    Nicole Tsz Yan Wong et al, 2023, BMC Ophthalmology CrossRef
19. Thyroid-Associated Orbitopathy: Evaluating Microstructural Changes of Extraocular Muscles and Optic Nerves Using Readout-Segmented Echo-Planar Imaging-Based Diffusion Tensor Imaging
    Huan-Huan Chen et al, 2020, Korean Journal of Radiology CrossRef
20. Image quality and evaluation ability of magnetic resonance imaging techniques for thyroid-associated ophthalmopathy: Dixon fat-suppression technique vs. spectral attenuated inversion recovery
    Kai Huang et al, 2023, Frontiers in Medicine CrossRef
21. Whole-orbit radiomics: machine learning-based multi- and fused- region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease
    Haiyang Zhang et al, 2024, Journal of Translational Medicine CrossRef